Age-related macular degeneration (AMD) is the leading cause of blindness among Canadians over the age of 50. Although the disease is not yet curable, there are promising new therapies in the research pipeline that may be available soon.
November 4, 2015
Age-related macular degeneration (AMD) is the leading cause of blindness among Canadians over the age of 50. Although the disease is not yet curable, there are promising new therapies in the research pipeline that may be available soon.
No one knows what causes age-related macular degeneration (AMD), but by some estimates it accounts for one-third of all cases of vision loss in Canada. Close to 80,000 Canadians are diagnosed with AMD annually. Nearly 90% of those with AMD have what’s called the dry (or nonexudative or atrophic) form, in which the light-sensitive cells in the macula slowly decay and yellow spots of fatty deposits called drusen appear on the macula.
Even though effective treatments for AMD are scarce, there is much you can do on the lifestyle front to preserve the vision you have:
Easily retrieve their info anytime you need it on any of your devices